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The 22q11.2 Deletion Syndrome (22q11.2DS) is the most common microdeletion syndrome in humans,
with a highly variable phenotype. This chromosomal region contains low copy repeat (LCR) sequences
that mediate non-allelic homologous recombination which predispose to copy number abnormalities at
this locus. This article describes three patients investigated for suspicion of 22q11.2DS presenting
atypical copy number abnormalities overlapping or not with the common w3 Mb deletion. They were
investigated by G-banding karyotype, Multiplex-ligation dependent probe ampliﬁcation (MLPA) and
array Genomic Hibridization (aGH). Clinical and molecular data were compared with literature, in order
to contribute to genotypeephenotype correlation. Atypical chromosomal abnormalities were detected:
3.6 Mb deletion at 22q11.21-q11.23 between LCRs BeF in patient 1 and approximately 1.5 Mb deletion at
22q11.21-q11.22 between LCRs DeE in patients 2 and 3. The breakpoints detected in patient 1 have not
been previously described. These ﬁndings exemplify the complexity and genetic heterogeneity observed
in 22q11.2 region and corroborates the idea that genetic modiﬁers contribute to the phenotypic vari-
ability observed in proximal and distal 22q11.2 deletion syndromes.
 2013 Elsevier Masson SAS. All rights reserved.1. Introduction
22q11.2 Deletion Syndrome (22q11.2DS) is the most common
microdeletion syndrome in humans, affecting approximately 1 in
4000e6000 live births [1,2]. This condition presents phenotype
variability including cardiovascular anomalies (typically con-
otruncal defects), palatal abnormalities, characteristic facial
appearance, immunodeﬁciency, endocrine dysfunctions, hypocal-
cemia, urogenital abnormalities, and a varying degree of cognitive
deﬁcits and intellectual disability [3e5].
The chromosome 22q11.2 region contains low copy repeat (LCR)
sequences that mediate non-allelic homologous recombination and
predispose to copy number abnormalities (i.e. deletions and du-
plications) [6e8]. Eight LCRs have been characterized at chromo-
some 22q11.2, designated 2e8 [7] or AeH [9] (Fig. 1).Genetics, Faculty of Medical
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deletion spanning LCR22-A to LCR22-D, that contains at least 30
genes, including TBX1. A corresponding proximal chromosome
22q11.2 duplication spanning LCR22-A to LCR22-D has also been
described, and it is associated with diverse phenotype abnormal-
ities. This duplication may overlap the 22q11.2DS phenotype but
also occurs in individuals with apparent normal phenotype [10e
13]. In a minority of patients with deletions or duplications at
proximal chromosome 22q11.2, a smaller 1.5 Mb region is involved,
spanning LCR22-A to LCR22-B [14e17].
Many studies have failed to show a correlation between the
clinical features and size of the common 3 Mb and proximal 1.5 Mb
22q11.2 deletions [3,15,18,19]. The high variable and mild pheno-
type of patients with 22q11.2 duplications that range from 3 to
6 Mb suggests that duplications are less deleterious than deletions
[10], and therefore are more likely to be inherited at reduced
penetrance [20].
A limited number of patients have been described with atypical
copy number abnormalities located on the proximal typical deleted
region with different breakpoints [13,20e26]. Also, atypical copy
number abnormalities spanning other LCRs, distal to the 3 Mb
Fig. 1. Atypical deletions (red boxes) and duplications (green boxes) of the proximal and distal 22q11.2 region. Orange boxes indicate largest and most frequently LCR22s, blue boxes
indicate smaller and less frequently involved LCR22s. Note that the exactly deletions or duplications are sometimes only estimated in reported cases as well as in patients of these
study. References of previously reported cases: 1 [59]; 2 [21]; 3 [22]; 4 [15]; 5 [60]; 6 [61]; 7 [58]; 8 [62]; 9 [42]; 10 [9]; 11 [23]; 12 [25]; 13 [57]; 14 [13]; 15 [63]; 16 [26]; 17 [27]; 18
[24]; 19 [28]; 20 [49]; 21 [64]; 22 [50]; 23 [29]; 24 [37]; 25 [30]; 26 [56]; 27 [51]; 28 [20]; 29 [31]; 30 [32]; 31 [33]; 32 [19]; 33 [65]; 34 [34]; 35 [66]; 36 [44]; 37 [45]; 38 [36]; 39
[35]; 40 [46] and 41 [48]. *Concurrent deletion and duplication in the same patient [modiﬁed from Tan et al., 2011].
Table 1
Description of atypical 22q11.2 copy number abnormalities and comparison be-
tween clinical ﬁndings detected on present cases and those with typical 22q11.2
Deletion Syndrome.
Patient 1 Patient 2 Patient 3 22q11.2 DSa
M.C. Molck et al. / European Journal of Medical Genetics 56 (2013) 515e520516common deleted region, have been described associated or not
with the 22q11.2 DS phenotype [24,27e36].
This article describes three patients investigated for suspicion of
22q11.2DS presenting atypical copy number abnormalities in the
22q11.2 region.Age (at last
evaluation)
12 yo 4 yo 4 yo 56%  5
years
Gender Male Female Female Evenly
distributed
Deletion/
duplication
interval
Del
LCR22-B
to F
Del
LCR22-D
to E
Del
LCR22-D
to E
Del LCR22-A
to B/D
Deletion Size Del 3.6 Mb Del 1.4 Mb Del 1.5 Mb 1.5e3.0 Mb
Birth weight
centile
50th -2nd DP < 3rd NR
Weight centile ND > 97th < 3rd 41% < 5th
Height centile < 3rd 50th75th 3rd10th NR
Head Circumference
centile
< -2nd DP -2nd DP -2nd DP NR
Congenital heart
disease
IVC þ
DORV
e AIVSD þ
PFO
74%
Palatal
abnormalities
e þ e 69%
Characteristic face e e e Common
Recurrent infections e þ e Common
Developmental
delay
þ þ þ 70e90%
Feeding problems þ þ þ 30%
Hearing loss e þ e 39%
Eye abnormalities þ þ e 69%
Neurological
abnormalities
e e e NR
Urinary tract
anomalies
e e e 37%
Gastrointestinal
anomalies
e þ e NR
Skeletal
abnormalities
e e þ NR
Genital anomalies e e e NR
Hypocalcemiab e e e 50%
Del, deletion; Dup, duplication; þ, presence; e, absence; IVC þ DORV, interventricular
communication and double outlet right ventricle; AIVSDþ PFO, apical interventricular
septal defect and patent foramen ovale; ND, Not Determined; NR, Not Reported.
a McDonald-McGinn et al. (1999).
b Retrospective data.2. Patient data
This study was approved by the Ethics Committee Board of
University of Campinas (Numbers 487/2009 and 433/2010). Writ-
ten informed consents were obtained from all participants, and
written permission to use the images in this study was also ob-
tained from the participated patients or their parents. All patients
were evaluated by clinical geneticists in a multicenter study about
22q11.2DS in Brazil, using a standardized form by Brazil Crânio-
Face Project for clinical data and complementary examinations.
These data and also pictures of the individuals are presented, on
Table 1 and Fig. 2, respectively.
Patient 1, a male, was referred for evaluation because of speech
difﬁculty at age 12 years. He is the eighth child of a healthy and
non-consanguineous couple (mother 36 years, father 46 years).
There is no relevant familial history. Pregnancy and delivery (at
term) were uneventful. Birth weight was 2.8 Kg (50th centile),
length 42 cm (below 3rd centile) and OFC 30.8 cm (below 3rd
centile). After 40 days he was readmitted because of congenital
heart disease (interventricular communication and double outlet
right ventricle) and underwent surgical correction. On dysmor-
phologic examination at 12 years he displayed: weight was not
mentioned, length 130 cm (below 3rd centile), OFC 48.5 cm (below
e 2nd DP centile), large nose with high nasal bridge (Fig. 2a). He
also presented developmental delay, feeding difﬁculties, short
stature and unspeciﬁed ophthalmic abnormalities. His nasoﬁbro-
scopy exam demonstrated adequate velopharyngeal function dur-
ing phonation (standard coronal).
Patient 2 is the second female child born to a healthy and non-
consanguineous couple (mother 36 years, father 35 years). There is
no relevant familial history. Pregnancy was uneventful. Delivery
was preterm at 30 weeks. Anthropometrical data at birth were:
Fig. 2. Facial features of affected individuals. a: Patient 1 at age 12 years, showing tubular nose. b: Patient 2 at age 4 years showing no major facial dysmorphisms, long philtrum. c:
Patient 3 at age 4 years. Note the horizontalized eyebrows, nose with prominent root and high bridge and thin upper lip.
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50th centiles) and OFC 25 cm (-2nd DP centile). The newborn
remained in neonatal intensive care unit for 2 months for unknown
reason. She presented mild motor delay and walked at 2 years.
Dysmorphologic examination at 4 years: weight 20.1 kg (above
97th centile), length 102 cm (between 50th and 75th centiles), head
circumference 47.5 cm (-2nd DP centile), no major facial dys-
morphisms, long philtrum (Fig. 2b), unilateral transforaminal left
cleft lip and cleft palate. Echocardiogram detected discrete
tricuspid insufﬁciency without hemodynamic repercussion. She
presented recurrent otitis, conductive hearing loss, strabismus,
feeding difﬁculty, constipation, and behavioral disturbance with
agitation and attention deﬁcit.
Patient 3 was the only female child of non-consanguineous
parents and she has a healthy paternal half-brother. A paternal
aunt with cleft lip and palate and the aunt’s daughter with short
stature and also a paternal second degree cousin with cleft lip and
palate were reported. Single umbilical artery was detected by ul-
trasound pregnancy. She was born small for gestational age with
weight 1.8 kg (below 3rd centile), length 40 cm (below 3rd centile)
and OFC was not mentioned. There are no records of delivery and
neonatal informations. She had dysphagia with spontaneous
improvement and developmental delay.
She was referred at age of 4 years for investigation of congenital
heart disease (apical interventricular septal defect and patent fo-
ramen ovale). At this time, the dysmorphologic examination
showed: weight 12.2 kg (below 3rd centile), length 93,7 cm (be-
tween 3rd and 10th centiles), OFC 46,5 cm (-2nd DP centile),
triangular face, large and anteverted ears with hypoplastic lobes,
horizontalized eyebrows, nose with prominent root and high
bridge, short philtrum, thin upper lip (Fig. 2c), mild pectus exca-
vatum, mild clinodactyly of the 5th ﬁngers and toes and mild
asymmetry of the lower limbs.3. Methods
G-banding karyotype at the level of 550 bands was performed
for all patients. Multiplex-ligation dependent probe ampliﬁcation
(MLPA) analysis was performed using SALSA MLPA kit P250 Di
George (A1 and B1 versions, MRC Holland). Data analysis was
made against up to 5 control samples using an in-house Excel
spreadsheet (National Genetics Reference Laboratory, Manchester,UK e available in http://www.ngrl.org.uk/Manchester/publications/
MLPA%20Spreadsheets). aGH analyses were performed using the
CytoScan HD chip (Affymetrix) and analyzed with the Chromo-
some Analysis Suite (ChAS) Software (Affymetrix).
4. Results
Patient 1: G-banding karyotype showed 47,XY,þmar[2]/46,XY
[48]. MLPA analysis showed an atypical deletion overlapping
proximal and distal 22q11.2 region and spanning the genomic re-
gion between LCR22-B and LCR22-F (Supporting Fig. 3a). aGH
analysis demonstrated a 3.6 Mb deletion at 22q11.21-q11.23
[20,311,903e23,953,390 e hg19] (Supporting Fig. 3b), conﬁrming
the MLPA result. Supernumerary marker chromosome could not be
identiﬁed by this technique. Patient 3’s mother MLPA analysis
showed normal result and father’s DNA was not available for ge-
netic testing.
Patient 2: G-banding karyotype was normal. MLPA analysis of
the 22q11.2 region revealed an atypical deletion of w1.6 Mb at
distal 22q11.2 region between LCR22-D and LCR22-E (Supporting
Fig. 4a). aGH analysis conﬁrmed a deletion of 1.4 Mb at 22q11.21-
q11.22 [21,465,661e22,962,196 e hg19] (Supporting Fig. 4b). The
parents were not available for genetic studies.
Patient 3: G-banding karyotype was normal. MLPA analysis
showed a de novo atypical deletion of w1.3 Mb at distal 22q11.2
region between LCR22-D and LCR22-E (Supporting Fig. 5a). The
aGH analysis conﬁrmed this alteration allowing the breakpoints
mapping: 1.5 Mb deletion at 22q11.21-q11.22 [21,465,661e
22,998,610 e hg19] (Supporting Fig. 5b). Patient 5’s mother and
father MLPA analysis were both normal.
5. Discussion
The majority of chromosome 22 genomic abnormalities are
caused by LCR-mediated non-allelic homologous misalignments
and unequal recombination (NAHR) intrachromosomally or inter-
chromosomally during meiosis [37]. In addition to the commonly
deleted/duplicated region (3 Mb, LCRs A through D) ﬂanked by
LCR22s at both proximal and distal breakpoints, several ‘nonstan-
dard’ deletions/duplications with variable breakpoints are caused
by different recombination mediated by the LCR22A to LCR22H.
Beyond LCRs-mediated NAHR mechanism, several other
M.C. Molck et al. / European Journal of Medical Genetics 56 (2013) 515e520518mechanisms were proposed to explain the formation of these copy
number abnormalities, such as nonhomologous end joining,
microhomology-mediated break-induced replication, and variable
number of tandem repeats-mediated genomic rearrangements
[38]. Precise determination of the breakpoints of ‘nonstandard’
deletions/duplications is an important alternative to characterize
the effects of genes at this region in 22q11.2DS phenotype and to
understanding the frequency and dynamic of rearrangements. In
this article, three patients presenting atypical copy number ab-
normalities overlapping or not with the common w3 Mb deletion
are reported.
The patient 1 had an unreported 3.2 Mb atypical deletion,
overlapping proximal and distal 22q11.2 region, between LCR22-B
and LCR22-F that excludes TBX1, HIRA and UFD1L gene. Even so,
he presented cardiac defect.
Even though the role of TBX1 in heart development was also
demonstrated in mouse models [39,40], there is some evidence for
additional heart genes within the common 3 Mb region such as
HIRA [41], UFD1L [42] and CRKL [43]. Therefore, it seems likely that
additional genes contribute to congenital heart defects in patients
with atypical deletions excluding TBX1, although positional effects
might be possible [24,36].
Patient’s 1 deletion is ﬂanked by LCR22-B and F, and partially
affects the region corresponding to the common 22q11.2DS and the
distal 22q11.2 deletion. It would be expected that this patient
presented clinical features related both to the proximal as the distal
22q11.2 deletions. The most common clinical features associated
with the atypical and the distal 22q11.2 deletions are a history of
prematurity, pre-natal and post-natal growth retardation and
development delay [44e46]. In common with the patient 1 herein
described, developmental delay was observed. Additionally, patient
1 had congenital heart disease, speciﬁcally interventricular
communication and double outlet right ventricle, and CRKL gene
might be a good candidate gene [23,44,46]. Mice homozygous for
Crkl null mutations exhibit defects in multiple cranial and neural
crest derivates, including conotruncal malformations [43]. Patient 1
had deletion of CRKL gene, corroborating with cardiac ﬁndings of
this patient.
The small supernumerary marker chromosome (sSMC) pre-
sented in patient 1 could not be identiﬁed by the aGH technique
due to lower frequency of somatic mosaicism. However, Liehr et al.
[47] reported that in the majority of cases with normal karyotype
presenting sSMC, the somatic mosaicism does not have any
detectable clinical effects and there are rare cases with altered
clinical outcomes due to mosaicism. Nevertheless is not possible to
exclude that these sSMC may have a clinical effect.
Patients 2 and 3 have a w1.5 Mb atypical deletion at distal
22q11.2 region between LCR22-D and LCR22-E. This ﬁnding implies
that not only these LCRs have a role in the mechanism of rear-
rangement by NAHR but also the BCRL module speciﬁcally may be
utilized as a substrate in NAHR causing 22q11.2 distal deletions
[9,37].
Phenotypic features of distal 22q11.2 microdeletions include
low birth weight, microcephaly and short stature [29e31,48],
which were seen in patients 2 and 3. Prematurity is common too
and was observed in patient 2. Although common, the skeletal
defects were usually minor, such as short ﬁfth ﬁngers or clino-
dactyly [36,48], which were observed in patient 3. Developmental
delay or cognitive impairment, reported in over than 80% of pa-
tients [36], were observed in both patients described here.
The typical facial gestalt of the proximal 22q11.2DS was absent
in those with distal 22q11.2 deletions [27,29e31]. Although there is
not a typical facial gestalt in those individuals with distal 22q11.2
deletions, the most common ﬁndings are a smooth, long philtrum,
thin upper lip, non-speciﬁc ear anomalies, arched eyebrows, deepset eyes and short or upslanting palpebral ﬁssures [29,30,34,36,48e
50]. Patient 3 had few similar features, such as ear anomalies and
thin upper lip. Additionally, she presented other features like
triangular face, horizontalized eyebrow, nose with prominent root
and high bridge and short philtrum.
Cardiac anomalies were observed in 50% of 22q11.2 distal de-
letions patients, usually septal defects and occasionally conotruncal
abnormalities [24,28,32,49,50], including truncus arteriosus,
bicuspid aortic valve, interrupted aortic arch and ventriculoseptal
defect [36]. It is reinforced by the presence of apical interventricular
septal defect and patent foramen ovale in patient 3.
Promising candidate genes for distal 22q11.2 deletion pheno-
type are ERK2/MAPK1, related to craniofacial and congenital heart
defects when conditionally inactivated in mouse neural crest
[43,51]; and YPEL1, a gene expressed in pharyngeal arch [52],
inactivation of which led to major craniofacial cartilage defects in
zebraﬁsh [53]. Additionally, genes possibly involved in growth
retardation, which was observed in both patients 2 and 3, are
UBE2L3 whose mutation has been associated with retarded pre-
natal growth in the mouse [54], and MIR130B which shows cell
growth promoting activity via silencing TP53INP1 [55].
6. Conclusions
The individuals herein reported share some characteristic fea-
tures with 22q11.2DS, which was the reason for the investigation.
However, different and unusual 22q11.2 abnormalities were detec-
ted in these patients. It included atypical deletions, two of them
mapped at the distal 22q11.2 region, not overlapping the common
deleted region in 22q11.2DS. To our knowledge, the breakpoints
described in patient 1 have not been reported previously.
The phenotypic data of patients described here contributes do
the clinical delineation of these atypical deletions. Although the
phenotype of individuals with distal 22q11.2 deletions is clinically
distinct from those with proximal deletions, copy number abnor-
malities of both regions may inﬂuence dosage-sensitive develop-
mental pathways. These ﬁndings exemplify the complexity of
rearrangements in the 22q11.2 region and the clinical heteroge-
neity observed in individuals with 22q11.2 deletions, which cor-
roborates the idea that genetic modiﬁers contribute to the
phenotypic variability found in these syndromes.
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